Benigay, Jimmy B.
HRN: 22-12-11 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/31/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/31/2022
11/10/2022
IV
500 Mg
Q8H
CAP-HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes